NCT07217704 - Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer. | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

November 12, 2025

Primary Completion Date

August 30, 2027

Study Completion Date

August 30, 2027

Conditions

Esophageal CancerGastric Cancer (GC)Gastroesophageal Junction

Interventions

DRUG

[18F]FAPI-74 PET/CT

\[18F\]FAPI-74 is a radioactive diagnostic agent indicated for use with Positron Emission Tomography (PET) imaging for the detection of Fibroblast Activation Protein (FAP) positive cancer cells and cancer-associated fibroblasts (CAF) in patients with gastric or esophageal cancers.